Pharmacy Chooses Bridgeline's Celebros Search to Elevate Their New eCommerce Website Experience

Rhea-AI Summary

Bridgeline Digital, Inc. (NASDAQ: BLIN) announced that a prominent pharmacy group in Ireland has chosen its Celebros search technology to enhance its new eCommerce site. The pharmacy, known for its customer-centric approach, aims to improve the online shopping experience using Celebros' advanced artificial intelligence, which can handle complex search queries. Features include natural language processing and instant search results, ensuring customers find products quickly. CEO Ari Kahn expressed confidence that this partnership will boost revenue while maintaining the pharmacy's commitment to excellent customer care.

Positive

• Partnership with a renowned pharmacy group enhances Bridgeline's market presence.
• Celebros search technology improves eCommerce site functionality, increasing customer satisfaction.
• Use of advanced AI and natural language processing may drive revenue growth.

Negative

• None.

WOBURN, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based marketing technology software, announced today that an award-winning pharmacy group in Ireland has selected Bridgeline's Celebros search to power their newly launched eCommerce site. The company will utilize Bridgeline's Celebros search to enhance their site search as a means of implementing its core value of excellent customer care into the online experience.

The pharmaceutical company has developed a nationally renowned reputation for putting the customer first and recognizes the importance of a seamless shopping experience. As they launched their new eCommerce site, the customer experience was top of mind with their leadership. The advanced artificial intelligence that Celebros provides gives the company the capabilities to accurately provide results for complicated search queries such as "diabetes" or symptoms such as "headache" or "pain relief."

The pharmacy will utilize Celebros’ natural language processing (NLP) as well as its instant search results. In addition, the latest generation of Celebros AutoComplete returns immediate query suggestions and matching product recommendations, making it easy for online customers to find products and get straight to the product detail page. This adaptable and highly-sophisticated solution is ideal for complicated search queries related to physical symptoms and difficult medication names.

"We're so pleased to be included in the online presence of our new customer," says Ari Kahn, CEO at Bridgeline. "I am confident that our Celebros software's advanced Artificial Intelligence will increase revenue for their business and ensure their legacy of excellent customer care as they enter the eCommerce market."

About Bridgeline Digital
Bridgeline helps companies grow online revenues by increasing their traffic, conversion rates, and average order values with its Unbound cloud-based marketing platform and suite of apps. To learn more, please visit www.bridgeline.com or call (800) 603-9936.

Contact:

Jeremy LaDuque

EVP of Marketing

Bridgeline Digital

press@bridgeline.com

FAQ

What partnership did Bridgeline Digital announce on January 13, 2021?

Bridgeline Digital announced a partnership with an award-winning pharmacy group in Ireland to implement its Celebros search technology for their new eCommerce site.

How will Bridgeline's Celebros search benefit the pharmacy's eCommerce site?

Celebros search will enhance the online shopping experience by providing accurate search results for complex queries and improving customer engagement through natural language processing.

What technology does Celebros search use?

Celebros search utilizes advanced artificial intelligence, including natural language processing and instant search capabilities.

What does the CEO of Bridgeline Digital say about the partnership?

CEO Ari Kahn expressed confidence that the Celebros software will increase revenue for the pharmacy and support its legacy of excellent customer care.